VeriMomIst trigonella foenum-graecum seed extract in der Schwangerschaft sicher?
No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
Pregnancy-safe products containing trigonella foenum-graecum seed extract
Related ingredients
Frequently asked questions
- Ist trigonella foenum-graecum seed extract in der Schwangerschaft sicher?
- No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
- Ist trigonella foenum-graecum seed extract während des Stillens sicher?
- No regulatory ban or harmonised lactation hazard was identified. Clinical reviews note fenugreek has been used as an oral galactagogue and that safety data in nursing mothers/infants are limited and mixed; this is an oral systemic context, not topical cosmetic use. There is no authoritative CIR or SCCS safety opinion flagging breastfeeding risk for the cosmetic extract. (PubMed review; ECHA/COSING).
- Ist trigonella foenum-graecum seed extract sicher für Babyhaut?
- No evidence of specific developmental or infant dermal toxicity was found and no regulatory restriction for use on infant skin was located. However, infant skin has higher permeability; for a botanical extract with measurable constituents, exposure via leave‑on topical use can be higher in babies — therefore exposure score is increased by +1 for 0–3 yr. No infant‑specific studies demonstrating placental/dermal transfer or endocrine disruption were found. (PubMed; COSING).
- Wie bewertet VeriMom trigonella foenum-graecum seed extract?
- VeriMom bewertet trigonella foenum-graecum seed extract mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu trigonella foenum-graecum seed extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu trigonella foenum-graecum seed extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.